Nanocrystal technology, drug delivery and clinical applications
- PMID: 18990939
- PMCID: PMC2626933
- DOI: 10.2147/ijn.s595
Nanocrystal technology, drug delivery and clinical applications
Abstract
Nanotechnology will affect our lives tremendously over the next decade in very different fields, including medicine and pharmacy. Transfer of materials into the nanodimension changes their physical properties which were used in pharmaceutics to develop a new innovative formulation principle for poorly soluble drugs: the drug nanocrystals. The drug nanocrystals do not belong to the future; the first products are already on the market. The industrially relevant production technologies, pearl milling and high pressure homogenization, are reviewed. The physics behind the drug nanocrystals and changes of their physical properties are discussed. The marketed products are presented and the special physical effects ofnanocrystals explained which are utilized in each market product. Examples of products in the development pipelines (clinical phases) are presented and the benefits for in vivo administration of drug nanocrystals are summarized in an overview.
Figures
References
-
- Anger S. Pharmazeutische Technologie. Berlin: Freie Universität; 2005. PhD Thesis.
-
- Bhol KC, Alroy J, Schechter PJ. Anti-inflammatory effect of topical nanocrystalline silver cream on allergic contact dermatitis in a guinea pig model. Clin Exp Dermatol. 2004;29:282–7. - PubMed
-
- Bhol KC, Schechter PJ. Suppressive effects of topical nanocrystal-line silver on allergic contact dermatitis in mice [abstract] Clin Invest Med. 2004;274:196.
-
- Bhol KC, Schechter PJ. Topical nanocrystalline silver cream inhibits expression of matrix metalloproteinase-9 in animal models of allergic contact dermatitis [abstract] . J Invest Dermatol. 2005a;1244:117.
-
- Bhol KC, Schechter PJ. Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis. Brit J Dermatol. 2005b;152:1235–42. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
